-
1
Mayor Isko has enough antibodies vs severe COVID-19 after 2nd dose of CoronaVac
izdano v Manila Bulletin (2021)Article -
2
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2 biopharmaceutical characterization: the NISTmAb case study
Izdano 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
3
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 3 defining the next generation of analytical and biophysical techniques
Izdano 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
4
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization
Izdano 2014Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
5
Bispecific antibodies
izdano v Springer ebooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
6
Antibody expression and production
izdano v Springer eBooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
7
-
8
-
9
-
10